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Abstract
Background: Melasma is a common hyperpigmentation disorder that has a significant effect on an individual’s
quality of life. However, there is no preference-based measurement that reflects quality of life in patients with
melasma. The objective of this study was to assess the impact of melasma on quality of life by using a health
status measurement - the Dermatology Life Quality Index (DLQI) - and a preference-based measurement -
Willingness to Pay (WTP) and Time Trade-Off (TTO).
Methods: A cross-sectional descriptive study was conducted. Seventy-eight patients with melasma who attended
the melasma clinic at Siriraj Hospital from February to March 2009 were recruited in this study. The Thai version of
the DLQI, questionnaires about WTP, standard TTO, and daily TTO were used to assess patients’ quality of life.
Results: Seventy-seven (98.7%) patients were female with a mean age of 47.8 ± 7.9 years. The mean health utility
based on standard TTO was 0.96. The utility obtained by the daily TTO method was 0.92 and was significantly
correlated with an economically inactive occupation (p < 0.05). The mean monthly WTP for the most effective
treatment was 1,157 baht (7.2% of monthly income), ranging from 100 to 5,000 baht (1 USD ~ 35.1 baht). The WTP
was significantly correlated with monthly personal income and the total DLQI score.
Conclusion: The WTP method could be a useful tool with which to measure the quality of life of patients with
melasma.
Background
Melasma is a common hyperpigmentation disorder that
occurs on sun-exposed areas of the skin, most commonly
involving the cheeks, nose, forehead, and chin. Melasma
affects more non-Caucasians than Caucasians [1-3]. In
2007, 1,169 melasma patients attended Siriraj Hospital
(4.1% of all dermatological outpatients). Melasma usually
begins with brownish macules and progresses to patches
with well-defined borders. The brownish patches have no
surface scale and have a symmetric distribution [4].
Melasma can have a significant effect on an individual’s
quality of life as it usually affects the face and causes dis-
figuring lesions [5]. The Melasma Area Severity Index
(MASI) is used by physicians to evaluate the severity of
melasma; however, this index does not indicate the effect
of melasma on the patients’ quality of life [6,7]. Dermatol-
ogists should incorporate health-related quality of life
measurements to help assess and monitor the progression
of their patients [8,9]. Treatment of melasma is challen-
ging because of the chronic and persistent nature of the
condition [10].
Health status measurement is well established and
widely used, capturing a detailed image of the impact of
dermatological conditions on different dimensions of qual-
ity of life. The limitation of this instrument is its potential
insensitivity to the overall impact of the disease on quality
of life [8,11]. The Dermatology Life Quality Index (DLQI)
is a generic health status measurement for all dermatologi-
cal diseases. This questionnaire contains general questions
and may not be specific enough to detect important
aspects of a particular disease [11]. The English version of
the DLQI was translated to Thai for use in Thai people
with skin diseases. This version has proven high validity
and good reliability [12]. The Melasma Quality of Life
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Previous studies demonstrated that the discriminatory
ability of MQoL is superior to that of the DLQI index
[9,13]. The MQoL scores were highly correlated with
DLQI and MASI scores [13]. The Thai version of the
MQoL has not been tested for validity and reliability and
thus cannot be used to evaluate Thai melasma patients.
A preference-based measurement is an assessment
method that is based on economic theory, allowing patients
to theoretically give up something of value (money, time,
risk of death) in order not to have the disease in question.
Thus, this method of assessment provides an insight into
the burden of disease as it relates to quality of life [8,11].
There are two types of preference-based measurement,
including utility measurement and contingent evaluation.
The most widely used direct utility measurement is Time
Trade-Off (TTO), in which patients exchange a proportion
of their future survival time in exchange for perfect health
or for the most effective treatment during a shortened life
span [11,14]. Another way that investigators have
attempted to capture patient preferences in dermatology is
through daily TTO. This method was modified by asking
patients to allocate time (hours per day) for imaginary ther-
apy [11,15]. Many dermatological studies have used this
method in patients with psoriasis,[8,16,17] atopic dermati-
tis,[8,16] and acne [16]. The Willingness To Pay method
(WTP) is a contingent evaluation requiring respondents to
imagine a market for a program or health benefit and to
reveal the maximum that they would be willing to pay for
that program or benefit. A higher WTP indicates a worse
quality of life and thus, as with utilities, WTP is a measure
of the quality of life disease burden. WTP has been used
for patients with psoriasis [8,15,18-20], port wine stains
[21], atopic dermatitis [8,22] and acne [23]. In Thailand,
the cost of melasma treatment is not covered by any pay-
ment scheme. The WTP for cosmetic dermatological pro-
cedures promises to become an increasingly relevant issue
as the prevalence of these procedures, which by definition
require out-of-pocket expenditure, continues to increase
[24]. Preference-based quality of life measurements (WTP
and TTO) have the advantage that they provide easy to
compare numerical values across different disease states
and demonstrate the detrimental effects of a disease on
q u a l i t yo fl i f et ot h o s ew h om a n a g er e s o u r c ea l l o c a t i o na n d
funding. They are appropriate measures for incorporating
quality of life into pharmaco-economic valuations [11].
However, there have not been any studies on preference-
based measurements in melasma patients.
The primary objective of the present study was to mea-
sure the health state utilities of patients with melasma
attending the melasma clinic at a university-based hospi-
tal by using health status (DLQI) and preference-based
(TTO, WTP) measurement. A secondary aim was to
determine the correlation between preference-based
(TTO, WTP) measurements, the health status measure-
ment (DLQI), clinical, and socioeconomic factors.
Methods
Patients and design of the study
This study was approved by the ethics committee on
research involving human subjects at Siriraj Hospital,
Bangkok, Thailand. It is a cross-sectional descriptive study
based on a questionnaire. The study population comprised
patients older than 18 years old, with clinically diagnosed
melasma who had attended the melasma clinic at the der-
matology outpatient service at the Faculty of Medicine,
Siriraj Hospital, Mahidol University, from February to
March 2009. All study subjects were contacted on a visit
to the clinic and invited to participate in the study.
Informed consent was obtained from all subjects partici-
pated in this study.
Intervention
All interviews were conducted by two physicians at the
clinic. The questionnaires consisted of three parts: a self-
administered questionnaire that included socio-demo-
graphic questions, questions about melasma and current
treatments, questions about heath status measurement
(DLQI), and preference-based measurements (TTO,
WTP). The patients were also examined by the interviewer
in order to assess the MASI score.
The Thai version of the DLQI measures how much a
skin problem has affected the patient’sl i f eo v e rt h ep r e -
vious 7 days. It consists of 10 items. Each question has five
possible answers: “not related”, “n o ta ta l l ”, “a little”, “a
lot”, and “very much”, which correspond to scores of 0, 0,
1, 2, and 3, respectively. The overall summary score ranges
between 0 (the best score) and 30 (the worst score) [12].
The WTP is assessed by a closed-ended questionnaire.
The bidding approach was used to determine the maxi-
mum WTP. Data in the questions adapt from studying of
the combination of topical medication that is the most
effective but has the least side effects in a period [25]. For
example, “Suppose the doctor prescribes the most effective
topical medication that is applied once daily for 8 weeks
resulting in complete clearing in 30% of treated patients
and significant improvement in 70% of treated patients for
1 year, but has a 1% incidence of side effects, how much
would you be willing to pay for this medication?” The
answer is the number of baht per treatment (8 weeks)
divided by 2 to find the number of baht per month.
The TTO is assessed by questionnaire. Data in the
questions adapt from studying of the combination of
topical medication that is the most effective but has the
least side effects in a period [25]. There are two types of
questions, including:
Leeyaphan et al. BMC Dermatology 2011, 11:16
http://www.biomedcentral.com/1471-5945/11/16
Page 2 of 81. Standard TTO: According to 2008 WHO data, the
life expectancy of Thai males and females is 69 and
75 years, respectively. The average age of melasma
patients is about 40 years [5] and most are female;
thus patients are expected to live for about another
30 years. In this study, the question asked was “Ima-
gine, you (patients) will live for another 30 years
with melasma. If the doctor prescribed the most
effective topical medication that should be applied
once daily for 8 weeks resulting in complete clearing
in 30% of patients and significant clearing in 70% of
patients for 1 year, but has a 1% incidence of side
effects, how many years would you exchange for this
medication?” The answer is “A” years per treatment.
The utility obtained by the standard TTO were
30-A/30.
2. Daily TTO: The question was “Imagine, if the
doctor prescribed the most effective topical medica-
tion that should be applied once daily for 8 weeks
resulting in complete clearing in 30% of patients and
significant improvement in 70% of patients, but has
a 1% incidence of side effects, how many hours per
day would you exchange for this medication?” The
answer is “B” hours per treatment. The utility
obtained by the daily TTO were 24-B/24.
Statistical method
Descriptive analysis was used to describe the frequency,
mean, standard deviation, and 95% confidence interval
(CI) of clinical, socioeconomic, DLQI, WTP, and TTO
data to define the impact on quality of life in melasma
patients.
The Spearman correlation was used to test correlation
between different methods. Multivariate regression ana-
lysis was carried out, using ordinary least squares, to
examine the relationship between preference-based mea-
surements (WTP, TTO) and disease characteristics, and
socioeconomic data such as monthly income, age, edu-
cation, and occupation. All statistical tests were carried
out with a 5% level of significance for two-sided tests.
All statistical data analyses were performed using SPSS
for Windows version 10.
Results
A total of 78 patients (mean age 47.8 years, range 28-66)
completed the study questionnaire and the interview. All
patients were clinically diagnosed as having melasma by
a dermatologist. Demographic, socioeconomic and clini-
cal data are shown in Table 1 and 2.
T h em e a ns c o r eo ft h eD L Q Iw a s7 . 3 .Q u e s t i o n2 ,
which questioned about embarrassment, displayed the
highest mean score. (Table 3) The reliability of this
DLQI in this study was demonstrated by Cronbach’s
alpha. It was 0.709 which represented homogeneity of
the study population.
The mean health utility based on the standard TTO
was 0.96. Multivariate analysis demonstrated that sex,
age, education, occupation, income, marital status,
Table 1 Demographic and clinical data of patients with
melasma
Characteristics No. of melasma patients
(n = 78)
Mean age ± SD (years) 47.8 ± 7.9
Sex:
- Female
- Male
77(98.7%)
1 (1.3%)
Marriage status:
- Married
- Single
- Divorced
51 (65.4%)
24 (30.8%)
3 (3.8%)
Education:
- Bachelor’s degree
- Secondary level
- Elementary level
- Vocational training
- Master’s degree
- Doctor’s degree
33 (42.3%)
17 (21.8%)
13 (16.7%)
10 (12.8%)
4 (5.1%)
1 (1.3%)
Occupation:
- Housewife
- Private employee
- Government employee
- Laborer
- Officer
- Nurses
25 (32.1%)
17 (21.8%)
16 (20.5%)
13 (16.7%)
5 (6.4%)
2 (2.6%)
Mean monthly personal income ± SD 23,391 ± 26,138 baht
(666.4 ± 744.7$)
Table 2 Melasma history and clinical data of melasma
patients.
Characteristics No. of melasma patients
(n = 78)
Mean age of onset of melasma ± SD
(years)
38.3 ± 9.2
Predisposing factors for melasma
- Sun exposure
- Oral contraceptive pill
- Pregnancy
- Sun-exposure due to occupation
- Sun-exposure due to sport
73 (93.6%)
11 (14.1%)
10 (12.8%)
9 (11.5%)
4 (5.1%)
Have family members with melasma 42 (53.8%)
The mean score on disease activity
(MASI)
14.8 ranging from 1.2-42
The main topical treatment patients
received
- Hydroquinone
- Sunscreen
- Retinoic acid
- Azalaic acid
- Steroid
74 (94.9%)
71 (91%)
65 (83.3%)
56 (71.8%)
41 (53.6%)
Mean duration of treatment ± SD
(years)
5.5 ± 6.2
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cantly correlated with utilities measured by the standard
TTO (p > 0.05). The detail of analysis including depen-
dent and independent variables are shown in Table 4.
On average, patients were willing to offer 1.9 ± 1.4 hours
per day for the most effective treatment. The utility
obtained by the daily TTO method was 0.92. An economic-
ally inactive occupation, such as housewife, was signifi-
cantly (p < 0.05) correlated with utility obtained by the
daily TTO. In other word, a melasma patient’sq u a l i t yo f
life was significantly lower if they had an economically inac-
tive occupation. However, sex, age, education, income, mar-
ital status, duration of treatment and MASI score were not
significantly correlated with utility measured by the daily
TTO. The regression analysis with stepwise method
demonstrated the value of R
2 and F statistic more than the
regression with enter method. Criteria of stepwise method
was entering when probability of F was ≤ 0.05 and remov-
ing when probability of F was ≥ 0.10. The summary model
had only occupation as independent variable. It excluded
variable of age, education, MASI score, married status,
income and duration of treatment. The correlation between
quality of life measuring by daily TTO and demographic-
socioeconomic-clinical factors was shown in Table 5.
The mean monthly WTP for the most effective treat-
ment in this period was 1,157 baht (33 USD), ranging
from 100 to 5,000 baht (2.8 USD-142.5 USD). Income was
significantly (p < 0.05) correlated with the WTP in a
regression analysis controlling for other clinical-socioeco-
nomic data. An increase in monthly personal income of
100 baht increased the WTP by 2 baht. Age, sex, educa-
tion, occupation, marital status, duration of treatment and
MASI score were not significantly correlated with mean
monthly WTP. The correlation between monthly WTP
and demographic-socioeconomic-clinical factors were esti-
mated by multivariate regression. The regression with
stepwise method had the value of R2 and F-statistic more
than the regression with enter method, so this study used
regression with stepwise method. The summary model
had income as independent variable. It excluded variable
of age, occupation, education, MASI score, married status
and duration of treatment. The correlation between
monthly WTP and demographic-socioeconomic-clinical
factors were shown in Table 6.
The mean monthly WTP was 7.2% of monthly personal
income. Multivariate analysis demonstrated that the
WTP in terms of relative monthly income was signifi-
cantly correlated with occupation and age (p < 0.05).
Melasma patients’ quality of life was significantly lower if
patients had an economically inactive occupation or were
Table 3 Percentage of responses to each question of the DLQI in melasma patients
Question Percentage Median DLQI
Not at all
(0)
A lot
(2)
Very much
(3)
Not relevant
(0)
1. Itchy/sore/painful/stinging skin 76.9 16.7 5.1 1.3 0 0
2. Embarrassment 25.6 21.9 26.9 25.6 0 2
3. Shopping/home 28.2 24.4 21.7 24.4 1.3 1
4. Clothes 61.4 24.4 10.3 2.6 1.3 0
5. Social activities 28.2 20.4 24.4 24.4 2.6 1
6. Sport 50 15.4 17.9 16.7 0 0.5
7. Working or studying 84 4.5 5.1 0 6.4 0
8. Interpersonal problems 59 11.5 12.8 1.3 15.4 0
9. Sexual difficulties 69.2 3.8 2.6 0 24.4 0
10. Treatment difficulties 67.9 21.8 6.4 0 3.9 0
Table 4 Multivariate analysis between quality of life from
standard TTO method and demographic- socioeconomic-
clinical data was estimated by ordinary least square
methods
Variable Coefficient t-Statistic p-value
C 0.912 9.44 0.000
AGE 1.78E-05 0.009 0.993
EDU 0.034 1.030 0.307
OCC 0.025 0.706 0.483
MASI 0.000 0.251 0.803
TR 0.001 0.525 0.601
MS 0.013 0.387 0.700
INC 1.40E-07 0.238 0.813
Dependent Variable: TTY.
R square: 0.028 Adjusted R square: -0.069
F-statistic: 0.288, p-value 0.956
Where:
TTY: Quality of life obtaining from standard TTO method
AGE: Age of patient (years)
EDU: Dummy variable which 1 if education level is bachelor or higher level
and 0 otherwise
OCC: Dummy variable which 1 = economic inactive occupation (housewife,
pensioner, unemployed) and 0 = otherwise
MASI: Score of MASI
TR: Duration of treatment (years)
MS: Dummy variable which 1 if marital status = married and 0 = otherwise
INC: Monthly personal income (Baht)
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ment and MASI score were not significantly correlated
with mean monthly WTP. The correlation between
impact on quality of life measuring by WTP(WTP/
income) and demographic-socioeconomic-clinical factors
estimated by multivariate regression. The regression with
stepwise method had the value of R2 and F-statistic more
than the regression with enter method, so this study used
regression with stepwise method. The summary model
had age and occupation as independent variable. It
excluded variable of education, MASI score, married sta-
tus and duration of treatment. The correlation between
impact on quality of life measuring by WTP and demo-
graphic-socioeconomic-clinical factors were shown in
Table 7.
The Spearman correlations between the total DLQI
score and the patients’ quality of life measuring by stan-
dard TTO, daily TTO and WTP were shown in Table 8.
Discussion
A previous study reported characteristics of melasma
patients who were mostly female with an average age of
about 40 years. Sun exposure was the most important
predisposing factor for melasma [5,26]. This study
demonstrated a similar result. A previous study reported
that 20-70% of melasma patients had family members
with melasma [5,27]. We found that 53.8% of patients
had relatives with melasma, mostly their mother and/or
sisters. The mean MASI score was 14.8, which was
slightly higher than in the previous study [27]. About half
of patients had educational level higher than bachelor’s
degree. Patients with higher education may pay more
attention to their images; thereby seeking for the treat-
ment of melasma. Most of patients received hydroqui-
none and sunscreen which were the main topical
treatments for melasma in Thailand.
The DLQI has been used to determine the health-
related quality of life in patients with skin problems and
has been considered to be superior, in terms of reliabil-
ity, to general (non-dermatological) measurements in
dermatological patients [11,28]. Previous studies have
reported a mean total DLQI score of 5.9-7.4 for
Table 5 Multivariate analysis between quality of life
measuring by daily TTO method and demographic-
socioeconomic-clinical factors
Variable Coefficient t-Statistic p-value
C 0.931 121.955 0.000
OCC -0.035 -2.629 0.010*
Dependent variable: TTD.
R square: 0.083 Adjusted R square: 0.071
F-statistic: 6.910, p-value 0.010
* Significant values (p-value < 0.05)
Where:
TTD: Quality of life obtaining from daily TTO method
OCC: Dummy variable which 1 = economic inactive occupation (housewife,
pensioner, unemployed) and 0 = otherwise.
Table 6 Multivariate analysis between monthly WTP and
demographic-socioeconomic-clinical factors
Variable Coefficient t-Statistic p-value
C 596.201 4.320 0.000*
INC 0.024 6.073 0.000*
Dependent Variable: MWTP.
R square: 0.327 Adjusted R square: 0.318
F-statistic: 36.877, p-value 0.000
* Significant values (p-value < 0.05)
Where:
MWTP: Monthly WTP (Baht)
INC: Monthly personal income (Baht).
Table 7 Multivariate analysis between impact on quality
of life from WTP/income method and demographic-
clinical-socio-economic factors
Variable Coefficient t-Statistic p-value
C 0.158 3.686 0.000*
AGE -0.002 -2.301 0.024*
OCC 0.044 2.902 0.005*
Dependent Variable: WTP/income.
R square: 0.125 Adjusted R square: 0.102
F-statistic: 5.380, p-value 0.007
* Significant values (p-value < 0.05)
Where:
WTP/income: Impact on quality of life obtaining from WTP method (monthly
WTP/monthly income)
AGE: Age of patient (years)
OCC: Dummy variable which 1 = economic inactive occupation (housewife,
pensioner, unemployed) and 0 = otherwise.
Table 8 Spearman correlation coefficient between quality
of life according to different methods of measurement
Correlation DLQI Standard
TTO
Daily
TTO
WTP/
INC
WTP
DLQI Coefficient 1 0.107 -0.176 0.240 0.226
p value - 0.352 0.122 0.035 0.047
Standard
TTO
Coefficient 1 0.266 0.009 0.150
p value - 0.019 0.936 0.191
Daily TTO Coefficient 1 -0.134 0.087
p value - 0.241 0.448
WTP/INC Coefficient 1 0.504
p value - 0.000*
WTP Coefficient 1
p value -
Where:
DLQI = total score of Dermatology Life Quality Index
Standard TTO = Quality of life measured by the standard Time Trade Off
method
Daily TTO = Quality of life measured by the daily Time Trade Off method
WTP = Monthly Willingness To Pay (baht/month)
WTP/INC = Impact on quality of life measured by the Willingness To Pay
method (monthly WTP/monthly income).
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Page 5 of 8psoriasis patients and 6.1-7.3 for atopic eczema patients
[8,29]. Using the Thai version of the DLQI, Kulthanan
et al. found that the mean overall DLQI score in Thai
patients with psoriasis, acne, vitiligo and melasma was
12.9, 10.6, 8.8 and 6.0, respectively. The score for mel-
asma patients was significantly higher than normal peo-
ple and patients with viral warts, seborrheic keratosis,
moles, and benign skin tumors [12]. The mean total
D L Q Is c o r ef o rm e l a s m ao f7 . 3r e p o r t e di nt h ep r e s e n t
study was slightly higher than that of the aforemen-
tioned study. This confirms that melasma has a signifi-
cant adverse impact on the individuals’ quality of life. A
previous study demonstrated that melasma has a greater
impact on the psychosocial rather than the physical
aspects of a patient’s life [30]. Similar to this study, the
most common positively answered questions in the
DLQI were associated with psychosocial aspects.
The health state utility was measured on a scale
between 0 (death) and 1 (full health) by the TTO. In the
current study, the mean health state utility of patients
with melasma was 0.96 according to the standard TTO
and 0.92 according to the daily TTO. Many studies on
dermatology have used the standard TTO in patients
with psoriasis [8,16,17,29], atopic dermatitis [8,16,29],
and acne,[16] finding utility values of 0.56-0.93, 0.64-
0.97, and 0.94, respectively. This implies that according
to the standard TTO the utility of melasma individuals
is as high as that of patients with psoriasis, atopic der-
matitis, and acne.
Schmitt et al. reported that health utilities obtained
using the standard TTO were independent of sex, age,
occupational status, income, and objective disease severity
[29]. Similarly, the present study demonstrated that utili-
ties obtained by the standard TTO method were indepen-
dent of sex, age, occupation, income, and MASI score.
The results from previous studies about correlation
between the DLQI and the standard TTO were inconclu-
sive. Lundberg et al. reported a significant correlation
between the DLQI score and utilities obtained by the stan-
dard TTO method [8]. In contrast, Schmitt et al. demon-
strated that health utilities obtained by the standard TTO
were independent of the impact on quality of life (DLQI)
[29]. Our study demonstrated no significant correlation
between DLQI and standard TTO. Thus, the correlation
between the DLQI and the standard TTO remains
uncertain.
Standard TTO has frequently been used to determine
quality of life in diseases with physical disability and life-
threatening characteristics [31,32]. Most dermatological
diseases are nonlife- threatening and impair patients’ psy-
chosocial rather than physical aspects. The standard
TTO may not be a good tool for measuring quality of life
in patients with dermatological diseases, and should only
be used in patients with more severe disease states
(involving more physical aspects or those that are more
life-threatening).
Schiffner et al. used the daily TTO to assess patients’
quality of life. This method appeared to provide the
patients with a realistic time schedule that was easier to
imagine. Using the daily TTO method, patients with port-
wine-stains (PWS) and psoriasis would exchange 1.2 and
2.8 hours per day for a cure, respectively [15,21]. The
impact on the quality of life measured using the daily
TTO in patients with melasma in the present study (1.9
hours) is between values obtained for PWS and psoriasis
patients. In this study the daily TTO was significantly cor-
related with an economically inactive occupation, but not
with total DLQI score. This implies that the daily TTO
was influenced by socioeconomic factors rather than qual-
ity of life.
Measures of individuals’ WTP is another approach with
which to assess health-related quality of life [8]. Interpreta-
tion of WTP results is complicated because of the differ-
ences in therapies and currencies. In this study the WTP
considered the most effective treatment of melasma
instead of an imaginary treatment because no long-term
cure is available. In Thailand, melasma patients have to
pay out-of-pocket to receive treatment. Therefore, the
WTP in this study should reflect the real impact of mel-
asma on quality of life and provide an important basis
upon which to expand treatment in the clinic as it is a real
situation. Moreover, this WTP could be used in further
cost-benefit analysis.
Lundberg et al. reported that patients’ WTP for the cure
of psoriasis and atopic eczema was about 9-14% and 8% of
the average personal income, respectively. These values
can be compared with the WTP for a cure in other dis-
eases including asthma and acne [8]. Schiffner et al.
reported that the WTP for a cure for PWS and psoriasis
was 11.8% and 14% of monthly income, respectively
[15,21]. Thus the impact on quality of life of melasma as
measured by WTP was as high as that of atopic eczema.
In 2007, the Thai National Economics and Social Develop-
ment office demonstrated that ‘non-poor’ Thai people
(income above poverty line, 1443 baht/capita/month)
spent 31.9, 2.7, 13.8 and 18.6% of monthly income on
food, clothes and footwear, housing and transportation,
respectively. Thus patients in this study were willing to
spend more on melasma treatment than on clothes and
footwear.
Schmitt et al. reported a parallel increase in WTP with
greater monthly income that was independent of sex,
age, occupation, and objective disease severity [29].
Similarly, we found that the mean monthly WTP was
significantly associated with monthly personal income
but was independent of sex, age, occupation, and MASI
score. Previous studies reported that the WTP was sig-
nificantly correlated with the DLQI questions [8,29]. We
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terms of relative monthly income were weakly (but sta-
tistically significantly) correlated with the total DLQI.
Therefore, additional studies with larger sample sizes
are needed to further confirm this association. And if
the correlation is proved to exist, WTP may be the use-
ful tool to measure dermatological patients’ quality of
life.
The correlation between individual demographic, clini-
cal, and socioeconomic characteristics and quality of life
based on the WTP and daily TTO demonstrates that
younger patients and patients with economically inactive
occupations have the worst quality of life due to melasma.
Dermatologists should pay more attention to treating and
caring for these groups of patients.
Limitations of this study included small sample size and
only melasma patients visiting the clinic were evaluated,
not the general population of people with melasma. Thus,
there could be a lot of people who aren’tb o t h e r e db ym e l -
asma and who don’t come to a dermatologist for an eva-
luation which will reflect the true WTP and TTO.
Conclusion
The WTP method could be a useful tool for measuring
the quality of life of patients with melasma.
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